In Vivo Postantibiotic Effect in a Thigh Infection in Neutropenic Mice
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The postantibiotic effect (PAE) is the suppression of bacterial growth that persists after limited exposure of organisms to antimicrobial agents. We demonstrated and standardized the in vivo PAE in a thigh infection model in neutropenic mice. Inhibitors of protein and nucleic acid synthesis induced PAEs of 1.4-7.5 h against aerobic gram-negative bacilli, whereas beta-lactam antibiotics did not induce significant PAEs. Against aerobic gram-positive cocci, cell wall-active agents and inhibitors of protein and nucleic acid synthesis induced PAEs of 1.2-7.1 h, except for penicillins, which did not induce PAEs against streptococci. With few exceptions the in vivo PAE correlated well with the PAE reported in prior in vitro studies. Residual drug in thigh tissue did not cause the PAE. Theoretically, the presence of a PAE may allow antimicrobial agents to be given more intermittently without organism regrowth after drug levels fall below the minimal inhibitory concentration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Postantibiotic Suppression of Bacterial Growth
Bundtzen, R. W., Gerber, A. U., Cohn, D. L., & Craig, W. A. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.1.28 · Cited by 311
Self-citationPowell, S. H., Thompson, W. L., Luthe, M. A., Stern, R. C., Grossniklaus, D. A., Bloxham, D. D., Groden, D. L., Jacobs, M. R., DiScenna, A. O., Cash, H. A., et al. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.5.918 · Cited by 272
Eagle, H., Fleischman, R., & Levy, M. (1953) · New England Journal of Medicine · doi:10.1056/nejm195303192481201 · Cited by 230
Bodey, G. P., Ketchel, S. J., & Rodriguez, V. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90242-0 · Cited by 206
Effect of schedule of administration on the therapeutic efficacy of penicillin
Eagle, H., Fleischman, R., & Musselman, A. D. (1950) · The American Journal of Medicine · doi:10.1016/0002-9343(50)90425-6 · Cited by 197
Persistent Effect of Antibiotics on Staphylococcus aureus after Exposure for Limited Periods of Time
McDonald, P. J., Craig, W. A., & Kunin, C. M. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/135.2.217 · Cited by 196
Self-citationMcDonald, P. J., Wetherall, B. L., & Pruul, H. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.1.38 · Cited by 187
Gerber, A., Craig, W. A., Brugger, H. P., Feller, C., Vastola, A. P., & Brandel, J. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.5.910 · Cited by 160
Self-citationPostantibiotic effect of imipenem on Pseudomonas aeruginosa
Bustamante, C. I., Drusano, G. L., Tatem, B. A., & Standiford, H. C. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.5.678 · Cited by 137
Selection of Aminoglycoside-Resistant Variants of Pseudomonas aeruginosa in an in Vivo Model
Gerber, A., Vastola, A. P., Brandel, J., et al. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/146.5.691 · Cited by 108
Cited by
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
“Second, prolonged PAEs are observed in vitro but not in vivo after streptococci are exposed to penicillin and cephalosporins [16, 17, 20].”
Self-citationCorrelation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., & Craig, W. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.831 · Cited by 720
Self-citationCraig, W. A. (1995) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(95)00053-d · Cited by 618
Self-citationSetting and Revising Antibacterial Susceptibility Breakpoints
Turnidge, J., & Paterson, D. L. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-06 · Cited by 578
Self-citationCraig, W. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00065-5 · Cited by 556
Self-citationSingle or multiple daily doses of aminoglycosides: a meta-analysis
Barza, M., Ioannidis, J. P., Cappelleri, J. C., & Lau, J. (1996) · BMJ · doi:10.1136/bmj.312.7027.338 · Cited by 450
A suggested approach to once‐daily aminoglycoside dosing.
Begg, E., Barclay, M., & Duffull, S. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05719.x · Cited by 420
In Vivo Pharmacodynamic Activity of Daptomycin
Safdar, N., Andes, D., & Craig, W. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.63-68.2004 · Cited by 370
Self-citationLeggett, J. E., Fantin, B., Ebert, S., Totsuka, K., Vogelman, B., Calame, W., Mattie, H., & Craig, W. A. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.2.281 · Cited by 354
Self-citationOnce versus thrice daily gentamicin in patients with serious infections
Prins, J. M., Buller, H. R., Speelman, P., Kuijper, E. J., & Tange, R. A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90137-6 · Cited by 350
Continuous infusion of beta-lactam antibiotics
Craig, W. A., & Ebert, S. C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2577 · Cited by 338
Self-citationOnce-daily aminoglycoside therapy
Gilbert, D. N. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.3.399 · Cited by 324
Andes, D., & van Ogtrop, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2116 · Cited by 192
Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model
Andes, D., Stamsted, T., & Conklin, R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.922-926.2001 · Cited by 180
“from the treated animals to grow 1 log10 CFU/kidney (T) after serum levels fell below the MIC for the organism (PAE 5 T 2 C) (22).”
BackgroundAntifungal Pharmacokinetics and Pharmacodynamics
Lepak, A. J., & Andes, D. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019653 · Cited by 134
“This phenomenon was first observed and well described in bacteria (Eagle and Musselman 1949; Vogelman and Craig 1985; Craig and Vogelman 1987; Vogelman et al. 1988; Craig 1998) but has also been described in antifungal therapy (Fig.”
BackgroundCD101: a novel long-acting echinocandin
Zhao, Y., Perez, W. B., Jiménez‐Ortigosa, C., Hough, G., Locke, J. B., Ong, V., Bartizal, K., & Perlin, D. S. (2016) · Cellular Microbiology · doi:10.1111/cmi.12640 · Cited by 81
Host Fatty Acid Utilization by Staphylococcus aureus at the Infection Site
Frank, M. W., Yao, J., Batte, J. L., Gullett, J. M., Subramanian, C., Rosch, J. W., & Rock, C. O. (2020) · mBio · doi:10.1128/mbio.00920-20 · Cited by 57
PHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS OF THERAPY OF EXPERIMENTAL ENDOCARDITIS
Carbon, C., Cremieux, A.-C., & Fantin, B. (1993) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30504-3 · Cited by 14
Metadata
- Authors
- Vogelman, B., Gudmundsson, S., Turnidge, J., Leggett, J., & Craig, W. A.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1988-02-01
- Volume
- 157
- Issue
- 2
- Pages
- 287-298
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2059275495
- Cited by
- 259
- References
- 23
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.